Chemoprevention of intestinal polyposis by COX-2 inhibition: From mouse to man: Ohshima M. Murai (Hata) N, Kargama S, Aguello M, Luk P, Kwong E, Taketo M, Evans JF (Banyu-Merck Research Center, Tsukuba, Japan; Merck Frosst Center for Therapeutic Research, Pointe-Claire Dorval, Quebec, Canada; University of Kyoto, Tokyo, Japan; and Merck and Co., Inc., West Point, Pennsylvania). Chemoprevention of intestinal polyposis in the Apcδ716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res 2001;61:1733–1740